Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
UNIWERSYTET JAGIELLONSKI is currently managing 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 4 distinct art units, indicating a high degree of technical diversity in the university's current patent applications. The 4 pending actions are being reviewed by 4 distinct examiners, which means every active matter is under the scrutiny of a different individual at the USPTO.
MCDOWELL, BRIAN E is the busiest examiner for the portfolio, currently overseeing 1 pending office action. This specific action is just one of the 4 total pending office actions currently facing the university. With 4 distinct art units involved, the university must navigate the varying procedural nuances of four different USPTO groups. The fact that 4 distinct examiners are involved suggests a fragmented prosecution landscape, requiring a varied strategy to address the unique perspectives of each examiner across four different divisions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCDOWELL, BRIAN E | 1 | 74.0% | +31.0% |
| KIEFER, DALTON EDWARD | 1 | 85.7% | +16.7% |
| SWIFT, CANDICE LEE | 1 | 56.6% | +37.2% |
| SPANGLER, JOSEPH RANKIN | 1 | 40.8% | +70.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18547242 | AN ARTIFICIAL PROTEIN-CAGE COMPRISING ENCAPSULATED THEREIN A GUEST CARGO | KIEFER, DALTON EDWARD | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18442296 | (E)-N-CINNAMOYLAMINOALKANOLS WITH MELANOGENESIS INHIBITORY ACTIVITY | MCDOWELL, BRIAN E | — |
| 17268596 | METHOD FOR CONJUGATION OF BIOMOLECULES AND NEW USE OF GOLD DONOR FOR BIOMOLECULAR COMPLEX FORMATION | SPANGLER, JOSEPH RANKIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18547256 | AN ARTIFICIAL TRAP-CAGE, ITS USE AND METHOD OF PREPARING THEREOF | SWIFT, CANDICE LEE | 4d overdue |
| 18442296 | (E)-N-CINNAMOYLAMINOALKANOLS WITH MELANOGENESIS INHIBITORY ACTIVITY | MCDOWELL, BRIAN E | — |
| 18547242 | AN ARTIFICIAL PROTEIN-CAGE COMPRISING ENCAPSULATED THEREIN A GUEST CARGO | KIEFER, DALTON EDWARD | — |
| 17268596 | METHOD FOR CONJUGATION OF BIOMOLECULES AND NEW USE OF GOLD DONOR FOR BIOMOLECULAR COMPLEX FORMATION | SPANGLER, JOSEPH RANKIN | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| 1652 | 1 |
| 1657 | 1 |
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18442296 | (E)-N-CINNAMOYLAMINOALKANOLS WITH MELANOGENESIS INHIBITORY ACTIVITY | MCDOWELL, BRIAN E | 1624 | §102§112 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18547242 | AN ARTIFICIAL PROTEIN-CAGE COMPRISING ENCAPSULATED THEREIN A GUEST CARGO | KIEFER, DALTON EDWARD | 1652 | §102§103§112DP | Non-Final OA | — | Pending | Oct 10, 2023 |
| 18547256 | AN ARTIFICIAL TRAP-CAGE, ITS USE AND METHOD OF PREPARING THEREOF | SWIFT, CANDICE LEE | 1657 | §112 | Final Rejection | 4d overdue | Pending | Aug 21, 2023 |
| 17268596 | METHOD FOR CONJUGATION OF BIOMOLECULES AND NEW USE OF GOLD DONOR FOR BIOMOLECULAR COMPLEX FORMATION | SPANGLER, JOSEPH RANKIN | 1656 | §103§112Other | Final Rejection | — | Pending | Feb 16, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIWERSYTET JAGIELLONSKI has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Brian E Mcdowell has the most, with 1 of UNIWERSYTET JAGIELLONSKI's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
